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Clitoral priapism is a rare condition that is associated with an extended duration of clitoral erection due 
to local engorgement of clitoral tissue resulting in pain. Although the pathophysiology is not completely 
understood, it has been associated with specific classes of medications, diseases that alter clitoral 
blood flow or others associated with small to large vessel disease. We present a case report of a 
26-year-old patient who developed clitoral priapism without a clear medication or disease related 
etiology. The patient was treated with opiates, imipramine, non-steroidal anti-inflammatory medication, 
and local ice packs. She recovered uneventfully. 
[WestJEM. 2008;9:235-237.]
INTRODUCTION
Clitoral priapism is a rare cause of clitoral pain. It is 
thought to be a result of alterations in local hemodynamics 
leading to incomplete venous or lymphatic drainage of 
the clitoral tissue, resulting in edema and tissue swelling 
with concomitant pain.1 Due to the increasing number of 
medications being prescribed that can cause priapism as 
well as the resultant deficiency in blood flow to the clitoral 
region, it is paramount for the emergency physician (EP) to 
diagnose and treat appropriately. The prolonged erection is 
not associated with sexual stimulation, can last from minutes 
to days, and is frequently uncomfortable.1,2 Embarrassment 
can preclude patients from describing the exact nature of their 
symptoms, emphasizing the importance of a complete physical 
exam that includes an evaluation of the clitoris. 
Clitoral priapism has been associated with medications 
producing alpha blockade, inhibition of serotonin reuptake, 
and non-SSRI antidepressants.1,3 It has also been associated 
with transitional cell carcinoma obstructing venous and 
lymphatic clitoral outflow.4,5 Since cases are rare, there 
is inadequate evidence to determine the incidence of this 
condition or the likelihood of a particular cause. However, it 
has been shown that discontinuing the offending agent can 
result in a therapeutic resolution within 24-72 hours.1,6 Other 
treatment modalities include imipramine, non-steroidal anti-
inflammatory medications (NSAIDs), ice packs, opiates, and, 
rarely, intracavernous injection of adrenaline.2,6-8 Presented 
here is a case of clitoral priapism of unknown etiology and no 
known risk factors. 
CASE REPORT
A 26-year-old gravida 4 para 2 TAB 2 African-American 
patient presented to the emergency department (ED) with 
a two-day history of pain following wiping of her urethra. 
The patient described her pain as constant, aching and sharp, 
and feared she cut herself near her urethra while wiping. She 
has not been sexually activity for several months and denied 
insertion of foreign bodies. She described swelling in the 
region of her clitoris and attempted to alleviate the symptoms 
with several hot baths with minimal relief. She denied a 
history of trauma, vaginal pain and discharge, prior similar 
symptoms, and changes in hair pattern or voice. She also 
denied fever, dysuria, suprapubic pain, and gastrointestinal 
symptoms. She denied recent medication use or recreational 
drug use. The patient’s obstetrical and uro-gynecologic history 
was significant for two first trimester therapeutic abortions 
for unintended pregnancies without complication, several 
urinary tract infections treated effectively, and chlamydia 
vaginitis treated as an outpatient. She states that all annual pap 
smears and pelvic examinations prior to her presentation were 
otherwise normal. The patient also denied a family history of 
sickle cell disease and cancer.
Her vital signs included a temperature of 37 degrees 
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per minute, and respiratory rate of 16 breaths per minute. She 
was alert, oriented, and in moderate discomfort lying supine 
on the gurney. She pointed to her clitoral region when asked 
to point to the area of maximal pain. Her pelvic exam revealed 
a firm, swollen and acutely tender clitoris and clitoral hood 
with minimal vulvar tenderness and swelling (Figure 1). Her 
external genitalia including labia were normal and without 
lesions, lacerations, or abrasions. She had no cervical motion 
tenderness, os was closed, and no masses or discharge were 
present. Uterus was midline and non-tender. Her head and 
neck, cardiopulmonary, abdominal, lymphatic, and extremity 
exams were unremarkable. 
Laboratory tests included an unremarkable urinalysis 
and a negative urine pregnancy test. The patient was given 
vicodin for pain control with minimal relief. A gynecology 
consultation recommended NSAIDS, imipramine, and ice 
packs. The patient was referred to her primary gynecologist 
and instructed to follow up within two days with precautions 
to return if loss of sensation, increased swelling, or persistent 
or worsening pain after 48 hours. Her follow-up was 
uneventful.  
DISCUSSION 
Priapism is defined as a persistent and painful erection of 
penile or clitoral tissue with a duration of more than six hours 
and is not associated with sexual arousal.2 Clitoral priapism is 
an infrequent cause of clitoral or vulvar pain and can result in 
unnecessary and extensive laboratory and radiographic testing 
if not diagnosed appropriately through the history and clinical 
examination.2 Although only infrequently associated with 
etiologies that can cause long-term morbidity, the episodes 
themselves can be incapacitating and can require multiple 
hospital or clinic visits for pain control, according to sporadic 
case reports in the literature.2 Often a vague history is obtained 
as a function of embarrassment and frequently the episode has 
abated by the time the clinician evaluates the patient, making 
it difficult to diagnose. The details of specific clitoral swelling 
followed by pain with concomitant erection of the clitoral 
tissue can be suggestive of the diagnosis. Often, patients will 
describe an episode of perceived vulvar or labial swelling or 
pain that leads to clitoral swelling, erection, and extensive 
pain.2 Others will describe symptoms of dysuria, anorgasmia, 
intestinal complaints, and even cramping pain in the pelvic 
or lower abdominal region within the episode of clitoral 
priapism.3 A search for antecedent or proximate causes should 
ensue, and would likely include a complete recent medication 
and illicit drug history, a complete physical and gynecological 
examination, relevant urine and pregnancy studies, and 
adjunct testing depending upon the physical exam and history 
findings. 
The mechanism of clitoral priapism is theorized to be 
similar to the pathophysiology of male priapism, which 
involves altered circulation of the corpora cavernosa and 
increased clitoral intracavernous pressure resulting in 
erection of the glans.9 Decreasing venous outflow results 
in increased blood volume and pressure in the corpora. 
Although in men an increase in arterial inflow is an additional 
mechanism for producing priapism, this does not appear to 
be a relevant etiology in women.9 Corporeal venous outflow 
obstruction is likely a result of the following causes: 1) alpha 
sympathomimetic blockade resulting in extended relaxation 
of corporal smooth muscle, 2) physical obstruction or sinus 
compression, and 3) venous drainage occlusion.2,7 
Several groups of medications have been associated 
with clitoral priapism. although the exact mechanism for 
producing clitoral engorgement and pain is unknown.1 Due 
to the increasing use of these agents, the condition may 
become more prevalent, which is why EPs should evaluate 
for this condition. Alpha adrenergic blocking agents resulting 
in smooth muscle relaxation and venous stasis in the corpus 
cavernosa may cause priapism.9 Priapism is also a known 
adverse effect of psychotropic medications1,10 and is a 
rare reported adverse effect of antidepressant treatment.11 
Trazodone, buproprion,10 citalopram,6 fluoxetine, paroxetine, 
bromocriptine, olazapine,12 and nefazodone10 have all been 
implicated as agents contributing to or responsible for 
episodes of clitoral priapism. Potent 5H2 receptor antagonists3 
have also been reported to cause priapism, although the 
mechanism is unclear since the majority of 5H2 antagonists 
have limited alpha blocking effects. Bromocriptine may 
act through an increase in oxytocin or spinal dopaminergic 
pathways, although clear evidence is lacking.1 
Additionally, authors have provided evidence to support 
the idea that, rarely, clitoral priapism is the result of a 
physical obstruction of venous or lymphatic drainage and 
have included transitional cell carcinoma as a cause.5 Sickle 
cell disease13-15 and spinal cord injury16 are known causes 
of priapism, with sickle cell far more common as a cause in 
males. Although this patient was of African-American decent, 
Figure 1.  Clitoral priapism of patient
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she had no family history of sickle cell disease and it is not 
thought to be the cause in her situation. 
If an anatomic source exists, often excision or other 
therapies need to be considered with the appropriate specialist. 
The complete workup must exclude other more common 
causes of clitoral or vulvar pain including urinary tract or pelvic 
infections, local trauma or abrasions, vulvovaginitis, contact 
dermatitis, and other causes of pelvic or abdominal pain. 
No specific treatment regimen has been proven to be 
effective in managing clitoral priapism. However, cause-
specific treatment frequently reverses the condition and has 
responded well, in case reports, to the usage of NSAIDS, 
cooling pads, and opiates, although their effectiveness is 
inconclusive.2,7,17,18 When the etiology in unknown, the course 
of treatment becomes more confused and uncertain. While 
several case reports have discussed the use of imipramine as 
the initial drug of choice, its effect is poorly understood.2,6,7 
More likely, the patient’s condition resolved because the 
offending agent was removed. Intracavernous administration 
of alpha agonists similar to the treatment of penile priapism 
has also been reported with success.8 Therefore, the accepted 
management involves removal of the offending agent, 
replacement with an agent from another therapeutic class, 
and coordinated treatment with imipramine for symptomatic 
episodes.7 
Some authors have advocated for the use of alpha adrenergic 
agonists in the acute episodes, including phenylpropanolamine 
or phenylephrine. These medications have similar alpha agonist 
activity when compared to imipramine but do not have the 
anti-cholinergic effects. One case highlights scorpion venom as 
a possible treatment modality.19 Urologic and/or gynecologic 
consultation may be required if symptoms cannot be abated with 
the above remedies. 
CONCLUSION
Clitoral priapism is a rare cause of vulvar pain and can 
be excruciating to the patient. Diagnosis may be difficult 
given embarrassment, vague history and inconclusive 
physical exam. Several causes has been linked to clitoral 
priapism including, alpha blocking agents, antidepressants, 
psychotropics, and 5H2 blockers. Other causes, such as 
cancer, have also been implicated. Treatment involves alpha 
agonists for acute attacks, imipramine, and symptomatic 
relief with NSAIDS and ice packs. Gynecology follow up is 
necessary for further evaluation.
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